Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cortilona is a topical corticosteroid cream containing 0.01% fluocinolone acetonide, developed and marketed by Offenbach Farmacéutica Mexicana. Fluocinolone acetonide is a synthetic fluorinated corticosteroid with medium potency that acts as an agonist of the glucocorticoid receptor. Upon binding, it translocates to the nucleus to modulate gene expression, leading to anti-inflammatory, antipruritic, and vasoconstrictive effects. Cortilona is approved for the treatment of various inflammatory, pruritic, and allergic skin conditions, including dermatitis, eczema, and psoriasis.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fluocinolone acetonide.